Report Overview

Indian Rett Syndrome market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Rett syndrome is a rare genetic neurological disorder that is more common among girls and leads to severeimpairmentaffecting their ability to speak, walk and eat. Rett syndrome is recognized in child between 6-18 months caused by mutations on the X-chromosome over a gene called MECP2. Rett syndrome can cause wide range of disabilities from mild to severe. Common symptoms of Rett syndrome include slowed growth, unusual eye movements, agitation and irritability, problems with hand movements, poor language skills, muscles and coordination problems, and trouble with breathing. Scientists found that children with this disorder have a mutation on the X chromosome. Health care professionals diagnosed Rett syndrome on the bases of MECP2 mutation. It is a rare condition so doctors also diagnosed other condition such as prenatal brain disorder, autism spectrum disorder, metabolic disorder, and cerebral palsy to confirm Rett syndrome.



Market Drivers

The rise in female population, expenditure on public healthcare programs and rising healthcare spending, availability of development of new drugs and use of advanced technologies drives the Indian rett syndrome market growth. However, increased focus on gene therapy treatment worldwide also boost up the Indian rett syndrome market. But, the high cost of treatment and rising R&D expenditure for the treatment of rett syndrome may hamper the rett syndrome market.